Literature DB >> 12871443

Thalidomide and thrombosis in multiple myeloma.

T Barbui1, A Falanga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12871443     DOI： 10.1046/j.1538-7836.2003.00084.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 2.  Current and emerging treatment options for patients with relapsed myeloma.

Authors:  Roberto Castelli; Roberta Gualtierotti; Nicola Orofino; Agnese Losurdo; Sara Gandolfi; Massimo Cugno
Journal:  Clin Med Insights Oncol       Date:  2013-08-19

3.  An absence of platelet activation following thalidomide treatment in vitro or in vivo.

Authors:  Jianlin Qiao; Yulu Wu; Xiaoqing Wu; Yun Liu; Xiaoqian Li; Wen Ju; Kunming Qi; Depeng Li; Elizabeth E Gardiner; Robert K Andrews; Lingyu Zeng; Kailin Xu
Journal:  Oncotarget       Date:  2017-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.